Patent directory · USPTO A61K / A61P
Patents matching “methotrexate”
10 pharma patents match "methotrexate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 10 pharmaceutical patents matching "methotrexate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12246064
Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate
granted -
US 12005060
Ophthalmic formulations of methotrexate
granted -
US 12005061
Ophthalmic formulations of methotrexate
granted -
US 11911385
Methotrexate treatment methods
granted -
US 11253604
Conjugate of methotrexate and peptide
granted -
US 10028911
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
granted -
US 9770414
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
granted -
US 8865728
Combinations comprising methotrexate and DHODH inhibitors
granted -
US 8501766
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
granted -
CA 2742910
THERAPIE DE COMBINAISON COMPRENANT UN INHIBITEUR DE DHODH ET DU METHOTREXATE POUR TRAITER UNE MALADIE AUTO-IMMUNE
granted